These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Immune thrombocytopenia in adults: an update.
    Author: Thota S, Kistangari G, Daw H, Spiro T.
    Journal: Cleve Clin J Med; 2012 Sep; 79(9):641-50. PubMed ID: 22949345.
    Abstract:
    Immune thrombocytopenia (ITP) in adults is a chronic disease resulting from increased platelet destruction and impaired platelet production. Splenectomy remains the most effective and durable treatment in cases that are refractory to first-line therapy, but its use has declined because of the availability of alternate medical therapy, the associated risk of infection, and concern for surgery-related complications. Rituximab (Rituxan) may be an effective alternative but carries the risk of immunosuppression.
    [Abstract] [Full Text] [Related] [New Search]